| |
| |
|
| Insider
Information: |
Klein Lawrence Otto |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
62,022 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,227,413 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,022 |
|
|
| Total
Value |
$2,227,413 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
CBO & COO |
2022-03-14 |
26,797 |
2019-01-02 |
0 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
Director |
2020-09-21 |
10,725 |
2020-09-21 |
0 |
Premium* |
|
|
Amplitude Healthcare Acquisition... |
AMHCU |
Director |
2022-10-12 |
24,500 |
2022-10-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2022-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
24,500 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2022-03-14 |
4 |
D |
$61.08 |
$75,067 |
D/D |
(1,229) |
26,797 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2022-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
28,026 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2022-03-11 |
4 |
D |
$62.56 |
$117,800 |
D/D |
(1,883) |
25,026 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,584 |
26,909 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-12-06 |
4 |
D |
$69.17 |
$773,666 |
D/D |
(11,185) |
22,325 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,667 |
33,510 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-09-13 |
4 |
D |
$117.86 |
$495,837 |
D/D |
(4,207) |
6,843 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
11,050 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-03-23 |
4 |
AS |
$126.97 |
$12,805,240 |
D/D |
(100,000) |
1,050 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-03-23 |
4 |
OE |
$14.43 |
$3,170,000 |
D/D |
88,000 |
101,050 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-03-10 |
4 |
D |
$124.15 |
$265,805 |
D/D |
(2,141) |
13,050 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,583 |
15,191 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-01-15 |
4/A |
OE |
$14.43 |
$235,700 |
D/D |
16,334 |
26,942 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-01-15 |
4 |
AS |
$211.44 |
$5,379,940 |
D/D |
(25,000) |
20,000 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2021-01-15 |
4 |
OE |
$12.57 |
$344,776 |
D/D |
25,010 |
36,334 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Director |
– • – |
2020-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,725 |
10,725 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2020-06-25 |
4 |
AS |
$75.18 |
$369,272 |
D/D |
(4,912) |
20,000 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2020-06-25 |
4 |
OE |
$12.57 |
$61,744 |
D/D |
4,912 |
24,912 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2020-06-24 |
4 |
AS |
$74.90 |
$4,942,292 |
D/D |
(65,088) |
20,000 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2020-06-24 |
4 |
OE |
$5.86 |
$558,707 |
D/D |
65,088 |
46,422 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2020-05-11 |
4 |
OE |
$5.86 |
$146,500 |
D/D |
25,000 |
45,000 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
CBO & COO |
• – – |
2020-05-11 |
4 |
AS |
$60.38 |
$1,509,971 |
D/D |
(25,000) |
20,000 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2019-07-11 |
4 |
AS |
$50.01 |
$421,171 |
D/D |
(8,421) |
20,000 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2019-07-11 |
4 |
OE |
$5.86 |
$49,347 |
D/D |
8,421 |
28,421 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
